Try our Advanced Search for more refined results

PROFESSIONAL DRUG COMPANY, INC. v. WYETH, INC.

  1. August 16, 2013

    FTC Wants To Extend Actavis To Authorized Generics Deals

    The Federal Trade Commission on Wednesday urged a New Jersey federal judge overseeing private antitrust litigation targeting an authorized generics deal between Wyeth LLC and Teva Pharmaceuticals USA Inc. to apply the U.S. Supreme Court's recent pay-for-delay ruling to the case.

  2. October 04, 2012

    FTC Can't Weigh In On Effexor Authorized Generics Case

    A New Jersey federal judge refused Wednesday to let the Federal Trade Commission weigh in on private antitrust litigation targeting an authorized generic deal between Wyeth LLC and Teva Pharmaceuticals USA Inc., ruling the agency's partiality made it an ill-suited amicus.

  3. August 13, 2012

    FTC Rips Wyeth, Teva Arguments In Effexor Antitrust Suit

    The Federal Trade Commission on Friday said Wyeth LLC and Teva Pharmaceuticals USA Inc.'s characterization of an authorized generic deal violates antitrust law, as the companies try to escape New Jersey litigation claiming they conspired to the stymie generic versions of the antidepressant Effexor XR.